Clinical Trials
1
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents
- Conditions
- Psoriatic ArthritisRheumatoid ArthritisAnkylosing Spondylitis
- First Posted Date
- 2018-03-20
- Last Posted Date
- 2018-03-21
- Lead Sponsor
- Opal Rheumatology Ltd.
- Target Recruit Count
- 5000
- Registration Number
- NCT03470688
- Locations
- 🇦🇺
Canberra Rheumatology, Canberra, Australian Capital Territory, Australia
🇦🇺Rheumatology ACT, Canberra, Australian Capital Territory, Australia
🇦🇺Susan Street Specialists Centre, Camperdown, New South Wales, Australia
News
No news found